| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis
|
Fontes, Filipa
|
|
2016
|
29 |
C |
p. 31-38
8 p.
|
artikel
|
| 2 |
Arm lymphoedema and upper limb impairments in sentinel node-negative breast cancer patients: A one year follow-up study
|
De Groef, An
|
|
2016
|
29 |
C |
p. 102-108
7 p.
|
artikel
|
| 3 |
Being more precise in assessing the value of precision medicine in breast cancer
|
Curigliano, Giuseppe
|
|
2016
|
29 |
C |
p. 186-187
2 p.
|
artikel
|
| 4 |
Breast adenomyoepithelioma and adenomyoepithelioma with carcinoma (malignant adenomyoepithelioma) with associated breast malignancies: A case series emphasizing histologic, radiologic, and clinical correlation
|
Moritz, August W.
|
|
2016
|
29 |
C |
p. 132-139
8 p.
|
artikel
|
| 5 |
Breast cancer in young women: Pathologic features and molecular phenotype
|
Sabiani, Laura
|
|
2016
|
29 |
C |
p. 109-116
8 p.
|
artikel
|
| 6 |
Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less
|
Toss, Angela
|
|
2016
|
29 |
C |
p. 223-230
8 p.
|
artikel
|
| 7 |
Concordance rates of biomarkers uPA and PAI-1 results in primary breast cancer vs. consecutive tumor board decision and therapy performed in clinical hospital routine: Results of a prospective multi-center study at certified breast centers
|
Jacobs, Volker R.
|
|
2016
|
29 |
C |
p. 208-212
5 p.
|
artikel
|
| 8 |
Consistency of breast density categories in serial screening mammograms: A comparison between automated and human assessment
|
Holland, Katharina
|
|
2016
|
29 |
C |
p. 49-54
6 p.
|
artikel
|
| 9 |
Current and emerging therapies of HER2-positive metastatic breast cancer
|
Hernández-Blanquisett, Abraham
|
|
2016
|
29 |
C |
p. 170-177
8 p.
|
artikel
|
| 10 |
Don't forget the dentist: Dental care use and needs of women with breast cancer
|
Lo-Fo-Wong, Deborah N.N.
|
|
2016
|
29 |
C |
p. 1-7
7 p.
|
artikel
|
| 11 |
Effects of a regional guideline for completion axillary lymph node dissection in women with breast cancer to reduce variation in surgical practice: A qualitative study of physicians' views
|
O'Brien, Mary Ann
|
|
2016
|
29 |
C |
p. 126-131
6 p.
|
artikel
|
| 12 |
Efficacy of localization of non-palpable, invasive breast cancer: Wire localization vs. Iodine-125 seed: A historical comparison
|
in ’t Hout, B.A.
|
|
2016
|
29 |
C |
p. 8-13
6 p.
|
artikel
|
| 13 |
Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy
|
De Santis, M.C.
|
|
2016
|
29 |
C |
p. 90-95
6 p.
|
artikel
|
| 14 |
Formal analysis of the surgical pathway and development of a new software tool to assist surgeons in the decision making in primary breast surgery
|
Catanuto, Giuseppe
|
|
2016
|
29 |
C |
p. 74-81
8 p.
|
artikel
|
| 15 |
From technological advances to biological understanding: The main steps toward high-precision RT in breast cancer
|
Leonardi, Maria Cristina
|
|
2016
|
29 |
C |
p. 213-222
10 p.
|
artikel
|
| 16 |
High prevalence of vitamin D deficiency in women with breast cancer: The first Chilean study
|
Acevedo, Francisco
|
|
2016
|
29 |
C |
p. 39-43
5 p.
|
artikel
|
| 17 |
IHC4 score plus clinical treatment score predicts locoregional recurrence in early breast cancer
|
Lakhanpal, Roopa
|
|
2016
|
29 |
C |
p. 147-152
6 p.
|
artikel
|
| 18 |
On the road to precision, there is more practical medicine to be implemented
|
Love, Richard R.
|
|
2016
|
29 |
C |
p. 188-191
4 p.
|
artikel
|
| 19 |
Paget's disease of the male breast in the 21st century: A systematic review
|
Adams, Scott J.
|
|
2016
|
29 |
C |
p. 14-23
10 p.
|
artikel
|
| 20 |
Perspectives from a weary surgical oncologist in Sub-Saharan Africa
|
Bird, Peter
|
|
2016
|
29 |
C |
p. 123-125
3 p.
|
artikel
|
| 21 |
Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk prediction
|
Fu, Mei R.
|
|
2016
|
29 |
C |
p. 231-240
10 p.
|
artikel
|
| 22 |
Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival
|
Carbognin, Luisa
|
|
2016
|
29 |
C |
p. 24-30
7 p.
|
artikel
|
| 23 |
Psycho-oncological support for breast cancer patients: A brief overview of breast cancer services certification schemes and national health policies in Europe
|
Neamţiu, L.
|
|
2016
|
29 |
C |
p. 178-180
3 p.
|
artikel
|
| 24 |
Radiotherapy for breast cancer: The predictable consequences of an unmet need
|
Rodin, Danielle
|
|
2016
|
29 |
C |
p. 120-122
3 p.
|
artikel
|
| 25 |
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience
|
Moscetti, L.
|
|
2016
|
29 |
C |
p. 96-101
6 p.
|
artikel
|
| 26 |
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer
|
Andreis, D.
|
|
2016
|
29 |
C |
p. 55-61
7 p.
|
artikel
|
| 27 |
Serum resistin is inversely related to breast cancer risk in premenopausal women
|
Georgiou, Georgia P.
|
|
2016
|
29 |
C |
p. 163-169
7 p.
|
artikel
|
| 28 |
Societal cost of subcutaneous and intravenous trastuzumab for HER2-positive breast cancer – An observational study prospectively recording resource utilization in a Swedish healthcare setting
|
Olofsson, Sara
|
|
2016
|
29 |
C |
p. 140-146
7 p.
|
artikel
|
| 29 |
Somatic gene mutation analysis of triple negative breast cancers
|
Dillon, J.L.
|
|
2016
|
29 |
C |
p. 202-207
6 p.
|
artikel
|
| 30 |
Surrogate end points for overall survival in breast cancer trials: A review
|
Fiteni, Frédéric
|
|
2016
|
29 |
C |
p. 44-48
5 p.
|
artikel
|
| 31 |
The genomic landscape of breast cancer and its interaction with host immunity
|
Luen, Stephen
|
|
2016
|
29 |
C |
p. 241-250
10 p.
|
artikel
|
| 32 |
The impact of tamoxifen brand switch on side effects and patient compliance in hormone receptor positive breast cancer patients
|
Zeidan, B.
|
|
2016
|
29 |
C |
p. 62-67
6 p.
|
artikel
|
| 33 |
The impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial: An institutional review
|
Le, Viet H.
|
|
2016
|
29 |
C |
p. 117-119
3 p.
|
artikel
|
| 34 |
The rise in bilateral mastectomies: Evidence, ethics, and physician's role
|
Yang, Y. Tony
|
|
2016
|
29 |
C |
p. 160-162
3 p.
|
artikel
|
| 35 |
The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival
|
Vasconcelos, Ines
|
|
2016
|
29 |
C |
p. 181-185
5 p.
|
artikel
|
| 36 |
Toxicity of dual HER2-blockade with pertuzumab added to anthracycline versus non-anthracycline containing chemotherapy as neoadjuvant treatment in HER2-positive breast cancer: The TRAIN-2 study
|
van Ramshorst, Mette S.
|
|
2016
|
29 |
C |
p. 153-159
7 p.
|
artikel
|
| 37 |
Treatment of the benign inverted nipple: A systematic review and recommendations for future therapy
|
Hernandez Yenty, Q.M.
|
|
2016
|
29 |
C |
p. 82-89
8 p.
|
artikel
|
| 38 |
Validated biomarkers: The key to precision treatment in patients with breast cancer
|
Duffy, Michael J.
|
|
2016
|
29 |
C |
p. 192-201
10 p.
|
artikel
|
| 39 |
Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional Portuguese cohort study
|
R. Ferreira, Arlindo
|
|
2016
|
29 |
C |
p. 68-73
6 p.
|
artikel
|
Tijdschrift beschrijving